Position in STTK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,696,028
+$909,753 QoQ
Shares Held
263,768
+22.4% QoQ
Ownership
0.344%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 71%
Shared 0%
None 29%
Common Shares in STTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STATE STREET CORP holds $28,945,516,906 across 423 Biotechnology names. STTK ranks #230 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,730,139 | $5,237,976,269 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,664,478 | $3,603,962,281 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,322,698 | $1,099,381,087 | |
| 4 | INSM |
INSMED Inc
|
5,551,699 | $907,813,820 | |
| 5 | INCY |
Incyte Corp
|
9,641,384 | $907,447,062 | |
| 6 | MRNA |
Moderna, Inc.
|
14,861,409 | $754,959,577 | |
| 7 | RPRX |
Royalty Pharma plc
|
10,989,851 | $527,183,152 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
16,186,613 | $448,369,180 |
All Filings in STTK
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,696,028 | 263,768 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $786,275 | 215,418 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $422,356 | 176,718 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $139,960 | 176,718 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $744,258 | 783,430 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $967,346 | 799,460 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,674,770 | 766,410 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,743,807 | 710,831 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,393,906 | 155,918 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $946,992 | 132,818 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $140,323 | 92,318 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $288,032 | 92,318 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $271,414 | 92,318 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $212,331 | 92,318 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $234,948 | 87,018 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $353,293 | 87,018 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,928,425 | 452,682 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,808,233 | 447,501 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $8,621,901 | 423,057 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $25,653,656 | 884,914 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $22,287,459 | 762,225 | Shares | Defined | 2021-07-09 | |
| 2020-12-31 | $10,420,837 | 198,833 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||